treatment.
In separate experiments using different tumour CEA preparations, 73 and 75% of the assayable CEA were retained after heating. This contrasted with results obtained using the two conventional assays and also the Abbott EIA kit. In these cases the assay values fell by 85%, 78% and 85% respectively. Similar results were obtained for CEA extracted from normal colon. In this experiment CEA was prepared from four separate specimens (Rogers & Keep, 1980) (227) where 65% of the activity was lost on heating. These experiments showed that antiserum 241 reacted only very weakly with heatlabile CEA as expected. Antisera to heat-treated CEA also reacted very weakly with CEA prepared from normal colon. This has previously been demonstrated with antiserum 241 by rocket electrophoresis (Rogers & Keep, 1980) and has now been confirmed by this technique with the additional antisera raised to heat-treated CEA (Figure 1 ). Whereas conventional anti-CEA (PK1G) produced rockets with perchloric acid extracts of normal colon at lmgml-l (120-200ng of CEAmg-1 of extract), antisera to heat-treated CEA failed to react at concentrations of extract up to 20mgml-1. These results suggest that CEA in normal colon may express an exceptionally high concentration of heat-labile binding sites which are not detected by antisera to heat-treated CEA.
Two approaches have been employed to ascertain whether these specificity differences can be attributed to different CEA populations. In an inhibition experiment, described in Figure 2 , the presence of a conventional antiserum PK1G did not block the binding of antibody 241 to radiolabelled CEA. This indicated that these antibodies react with unrelated binding sites. In addition, the maximum binding of CEA label to both antibodies was 56% at the greatest concentration of antibody 241 only dropping to 46% at the lowest concentration showing that the majority of CEA molecules expressed both binding sites. A residual population of CEA, -10%, appeared to express only 241-binding sites.
These results have been confirmed by an affinity chromatography method. Radiolabelled CEA, applied to a column of 241-Sepharose, was used to prepare 241-binding CEA. This was then applied to a column of PKIG-Sepharose and the proportion of bound and non-binding CEA estimated. Eightyfour percent of the 241-binding CEA recovered was given by CEA isolated from normal colon tissue (well f). After heat-treatment of normal colon CEA (well e) no detectable reaction was observed.
(B) Rocket electrophoresis in 1% agarose gel containing the absorbed goat antiserum against heat-treated CEA (1%) demonstrating a single rocket with tumour CEA (well 2) and failure to react with CEA isolated from normal colon (well 1). (C) Repeat of experiment (B) but with agarose gel containing absorbed rabbit antiserum 241 against heattreated CEA (1% decrease in subsequent assay value (Keep & Rogers, 1979) . A similar masking effect was also implicated in an assay of serum samples from patients with colorectal cancer (Kim et al., 1979) . It is likely that components in serum, which have been shown to bind to CEA, such as IgG and IgM (Harvey et al., 1978; Pompecki, 1979; Pressman et al., 1979) , may confer heat stability on otherwise heat-labile determinants.
In conclusion this study has confirmed our earlier work showing that conventional anti-CEA antisera can recognise heat-labile as well as heat-stable binding sites on CEA. We have now provided evidence that, although these sites are immuno-P logically distinct, they are present on the same molecular species of CEA thus ruling out the possibility of a major subset of CEA with greater cancer specificity. The results suggest that heat stability of CEA antigens may depend on some form of protection of the binding sites by an appropriate configuration of the oligosaccharide chains and this can be mimicked by components in human serum. Antisera raised to heat-treated CEA recognise mainly the heat-stable determinant. We are currently producing monoclonal antibodies against heat-treated CEA as this may lead to further information on the importance of heatstable epitopes with respect to tumour specificity and detection.
We would like to thank Drs P. Burtin and P. Gold for donating a purified sample of NCA and the G61 antiserum respectively. This work was funded by the Medical Research Council. Purified tumour-derived CEA (1420 yg by assay) was applied to a column of Con A-Sepharose and the CEA assayed (PKIG assay) in the non-binding fraction and the bound fraction eluted with 20% methyl glucoside. The same amount of CEA was heat-treated (assay value after heating -620pg) and again the CEA determined in the Con A non-binding and bound fractions.
The experiment was repeated with CEA isolated from normal colon (3.17/.Ig before heating and 0.53 jig after heating). All column fractions were dialysed against 0.1 M phosphate buffer, pH7, before assay. Results were expressed as a percentage of the CEA recovered from the affinity column. 
